We are live on ! Find out more
MYOK

MyoKardia, Inc. Common Stock
MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

Back to rankings

71 hedge funds and large institutions have $195M invested in MyoKardia, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 31 increasing their positions, 9 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

244% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 9

82% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 11

13% more funds holding

Funds holding: 63 → 71 (+8)

16% less capital invested

Capital invested by funds: $233M → $195M (-$38.3M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
71
Holders Change
+8
Holders Change %
+12.7%
% of All Funds
1.77%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
31
Reduced
9
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$7.16M
2
PHS
PFM Health Sciences
California
+$5.11M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$1.73M
4
CC
Casdin Capital
New York
+$1.62M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.56M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.93M
2
CAM
Cormorant Asset Management
Massachusetts
-$2.48M
3
DCM
Driehaus Capital Management
Illinois
-$1.61M
4
DM
Deerfield Management
New York
-$1.16M
5
DCM
Dialectic Capital Management
Connecticut
-$984K

MYOK Hedge Fund Activity: Q4 2016 in Review

71 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q4 2016, worth a combined $195M — down 16% from $233M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new MYOK positions and 11 closed out — a net gain of 9 holders — while 31 added to existing stakes and 9 trimmed.

The largest buyer was Millennium Management, adding an estimated $7.16M. The largest seller was Wellington Management Group, cutting an estimated $4.93M.

  • 71 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q4 2016, up from 63 in Q3 2016.
  • Funds reported $195M of MyoKardia, Inc. Common Stock stock for Q4 2016, down 16% quarter-over-quarter.
  • 20 funds opened new MyoKardia, Inc. Common Stock positions in Q4 2016 and 11 closed out, a net change of +9 holders.
  • The largest MyoKardia, Inc. Common Stock buyer in Q4 2016 was Millennium Management, an estimated $7.16M added.
  • The largest MyoKardia, Inc. Common Stock seller in Q4 2016 was Wellington Management Group, an estimated $4.93M sold.

Based on aggregated 13F filings for Q4 2016.